FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 337:203-204 July 17, 1997 Number 3 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article PubMed Citation

To the Editor: In their letter reporting the use of a continuous infusion of acyclovir to treat severe hemorrhagic varicella (March 6 issue),¹ Kakinuma and Itoh describe serologically confirmed infection with varicella-zoster virus in a patient with leukemia who had no response to the conventional regimen of therapy. However, the conventional-regimen dose of 250 mg of intravenous acyclovir every eight hours that was used in this 40-year-old woman is well below the dose of acyclovir recommended to treat varicella-zoster virus infection in immunocompromised patients -- namely, 10 mg per kilogram of body weight every eight hours.²

From the stated continuous-infusion . . . [Full Text of this Article]

References

Related Letters:

A Continuous Infusion of Acyclovir for Severe Hemorrhagic Varicella
Kakinuma H., Itoh E.
Extract | Full Text  
N Engl J Med 1997; 336:732-733, Mar 6, 1997. Correspondence

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.